The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was named:
"Immunoglobulins
".
FunFam 356: Low affinity immunoglobulin gamma Fc region recept...
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 29 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
7 | A0A0B4J2J0 (/IPI) A0A0G2K3P6 (/IPI) P12314 (/IPI) P12318 (/IPI) P20489 (/IPI) P31994 (/IPI) P31995 (/IPI) |
IgG binding GO:0019864
Interacting selectively and non-covalently with an immunoglobulin of an IgG isotype.
|
5 | P08101 (/IDA) P26151 (/IDA) P31994 (/IDA) Q63203 (/IDA) Q63203 (/IDA) |
IgG receptor activity GO:0019770
Combining with an immunoglobulin of an IgG isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
3 | A0A0B4J1G0 (/IDA) P08508 (/IDA) P08508 (/IDA) |
IgG receptor activity GO:0019770
Combining with an immunoglobulin of an IgG isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
3 | P08508 (/IMP) P08508 (/IMP) P26151 (/IMP) |
IgG binding GO:0019864
Interacting selectively and non-covalently with an immunoglobulin of an IgG isotype.
|
3 | P08508 (/IMP) P08508 (/IMP) P26151 (/IMP) |
IgE receptor activity GO:0019767
Combining with an immunoglobulin of the IgE isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
2 | A0A0B4J1G0 (/IDA) P20489 (/IDA) |
Immunoglobulin binding GO:0019865
Interacting selectively and non-covalently with an immunoglobulin.
|
2 | Q63203 (/IDA) Q63203 (/IDA) |
Leukotriene receptor binding GO:0031774
Interacting selectively and non-covalently with a leukotriene receptor.
|
2 | A0A0B4J2J0 (/IPI) A0A0G2K3P6 (/IPI) |
Immunoglobulin receptor binding GO:0034987
Interacting selectively and non-covalently with one or more specific sites on an immunoglobulin receptor molecule.
|
2 | P08508 (/ISO) P08508 (/ISO) |
Amyloid-beta binding GO:0001540
Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
|
1 | P31994 (/IPI) |
Amyloid-beta binding GO:0001540
Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
|
1 | P08101 (/ISO) |
Amyloid-beta binding GO:0001540
Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
|
1 | P31994 (/TAS) |
Transmembrane signaling receptor activity GO:0004888
Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
|
1 | P31995 (/NAS) |
Immunoglobulin receptor activity GO:0019763
Combining with the Fc region of an immunoglobulin protein and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
1 | Q92637 (/NAS) |
IgE receptor activity GO:0019767
Combining with an immunoglobulin of the IgE isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
1 | P20489 (/IMP) |
IgE receptor activity GO:0019767
Combining with an immunoglobulin of the IgE isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
1 | H0VDZ8 (/ISS) |
High-affinity IgE receptor activity GO:0019768
Combining with high affinity with an immunoglobulin of the IgE isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
1 | P12371 (/TAS) |
IgG receptor activity GO:0019770
Combining with an immunoglobulin of an IgG isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
1 | H0VDZ8 (/ISS) |
Low-affinity IgG receptor activity GO:0019772
Combining with low affinity with an immunoglobulin of an IgG isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
1 | P31994 (/IDA) |
Low-affinity IgG receptor activity GO:0019772
Combining with low affinity with an immunoglobulin of an IgG isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
1 | P08101 (/ISO) |
IgE binding GO:0019863
Interacting selectively and non-covalently with an immunoglobulin of the IgE isotype.
|
1 | P20489 (/IDA) |
IgE binding GO:0019863
Interacting selectively and non-covalently with an immunoglobulin of the IgE isotype.
|
1 | P20489 (/IMP) |
IgE binding GO:0019863
Interacting selectively and non-covalently with an immunoglobulin of the IgE isotype.
|
1 | P12371 (/TAS) |
IgG binding GO:0019864
Interacting selectively and non-covalently with an immunoglobulin of an IgG isotype.
|
1 | P08101 (/ISO) |
Immunoglobulin binding GO:0019865
Interacting selectively and non-covalently with an immunoglobulin.
|
1 | P08101 (/ISO) |
Leukotriene receptor binding GO:0031774
Interacting selectively and non-covalently with a leukotriene receptor.
|
1 | P26151 (/ISO) |
Immunoglobulin receptor binding GO:0034987
Interacting selectively and non-covalently with one or more specific sites on an immunoglobulin receptor molecule.
|
1 | P27645 (/IDA) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
1 | P31994 (/IPI) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
1 | P08101 (/ISO) |
There are 142 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
5 | O75015 (/TAS) P08637 (/TAS) P12314 (/TAS) P12371 (/TAS) P31994 (/TAS) |
Cell surface receptor signaling pathway GO:0007166
A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
5 | P08101 (/IMP) P08508 (/IMP) P08508 (/IMP) P20489 (/IMP) P26151 (/IMP) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
4 | A0A0B4J2J0 (/IEP) A0A0G2K3P6 (/IEP) Q63203 (/IEP) Q63203 (/IEP) |
Antibody-dependent cellular cytotoxicity GO:0001788
Cytolysis of target cells by natural killer cells, eosinophils, neutrophils, monocytes, or macrophages following engagement of antibodies bound to the target cells by Fc receptors on the effector cells.
|
3 | P08508 (/IMP) P08508 (/IMP) P26151 (/IMP) |
Positive regulation of type IIa hypersensitivity GO:0001798
Any process that activates or increases the frequency, rate or extent of type IIa hypersensitivity, a type of inflammatory response.
|
3 | P08508 (/IMP) P08508 (/IMP) P26151 (/IMP) |
Positive regulation of type III hypersensitivity GO:0001805
Any process that activates or increases the frequency, rate or extent of type III hypersensitivity, a type of inflammatory response.
|
3 | P08508 (/IMP) P08508 (/IMP) P26151 (/IMP) |
Positive regulation of type I hypersensitivity GO:0001812
Any process that activates or increases the frequency, rate or extent of type I hypersensitivity, a type of inflammatory response.
|
3 | P08508 (/IMP) P08508 (/IMP) P20489 (/IMP) |
Serotonin secretion GO:0001820
The regulated release of serotonin by a cell. Serotonin (5-hydroxytryptamine, or 5-HT) is a monoamine synthesised in serotonergic neurons in the central nervous system, enterochromaffin cells in the gastrointestinal tract and some immune system cells.
|
3 | P08508 (/IDA) P08508 (/IDA) P20489 (/IDA) |
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
|
3 | P31994 (/IDA) Q63203 (/IDA) Q63203 (/IDA) |
Phagocytosis, recognition GO:0006910
The initial step in phagocytosis involving adhesion to bacteria, immune complexes and other particulate matter, or an apoptotic cell and based on recognition of factors such as bacterial cell wall components, opsonins like complement and antibody or protein receptors and lipids like phosphatidyl serine, and leading to intracellular signaling in the phagocytosing cell.
|
3 | P08508 (/IMP) P08508 (/IMP) P26151 (/IMP) |
Phagocytosis, engulfment GO:0006911
The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis.
|
3 | P08508 (/IMP) P08508 (/IMP) P26151 (/IMP) |
Fc-gamma receptor signaling pathway involved in phagocytosis GO:0038096
An Fc-gamma receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes.
|
3 | P08637 (/TAS) P12314 (/TAS) P12318 (/TAS) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
3 | A0A0B4J2J1 (/IEP) A0A0G2K8U8 (/IEP) Q6XPU4 (/IEP) |
Antigen processing and presentation of exogenous peptide antigen via MHC class I GO:0042590
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules.
|
3 | P08508 (/IMP) P08508 (/IMP) P26151 (/IMP) |
Positive regulation of phagocytosis GO:0050766
Any process that activates or increases the frequency, rate or extent of phagocytosis.
|
3 | P08508 (/IMP) P08508 (/IMP) P26151 (/IMP) |
Regulation of immune response GO:0050776
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
3 | P08508 (/IMP) P08508 (/IMP) P26151 (/IMP) |
Regulation of immune response GO:0050776
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
3 | P08637 (/TAS) P12314 (/TAS) P31994 (/TAS) |
Regulation of sensory perception of pain GO:0051930
Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal.
|
3 | A0A0B4J2J1 (/IMP) A0A0G2K8U8 (/IMP) Q6XPU4 (/IMP) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
3 | A0A0B4J2J1 (/IDA) A0A0G2K8U8 (/IDA) Q6XPU4 (/IDA) |
Positive regulation of neuron death GO:1901216
Any process that activates or increases the frequency, rate or extent of neuron death.
|
3 | P08101 (/IMP) Q63203 (/IMP) Q63203 (/IMP) |
Cellular response to amyloid-beta GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
3 | P08101 (/IMP) Q63203 (/IMP) Q63203 (/IMP) |
Positive regulation of response to endoplasmic reticulum stress GO:1905898
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
|
3 | P08101 (/IMP) Q63203 (/IMP) Q63203 (/IMP) |
Positive regulation of type I hypersensitivity GO:0001812
Any process that activates or increases the frequency, rate or extent of type I hypersensitivity, a type of inflammatory response.
|
2 | P08508 (/IDA) P08508 (/IDA) |
Immune complex clearance GO:0002434
A process directed at removing immune complexes from the body. Immune complexes are clusters of antibodies bound to antigen, to which complement may also be fixed, and which may precipitate or remain in solution.
|
2 | Q63203 (/IDA) Q63203 (/IDA) |
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO:0002479
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.
|
2 | P12314 (/TAS) Q92637 (/TAS) |
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
|
2 | P12314 (/TAS) Q92637 (/TAS) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
2 | P31995 (/NAS) Q92637 (/NAS) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
2 | P12314 (/TAS) P31994 (/TAS) |
Response to bacterium GO:0009617
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium.
|
2 | P08101 (/IMP) P26151 (/IMP) |
Neutrophil chemotaxis GO:0030593
The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
|
2 | P08508 (/IMP) P08508 (/IMP) |
Endocytic recycling GO:0032456
The directed movement of membrane-bounded vesicles from recycling endosomes back to the plasma membrane where they are recycled for further rounds of transport.
|
2 | Q63203 (/IDA) Q63203 (/IDA) |
Negative regulation of neutrophil apoptotic process GO:0033030
Any process that stops, prevents, or reduces the frequency, rate, or extent of neutrophil apoptotic process.
|
2 | Q63203 (/IMP) Q63203 (/IMP) |
Positive regulation of tumor necrosis factor biosynthetic process GO:0042535
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
|
2 | P08508 (/IMP) P08508 (/IMP) |
Neutrophil degranulation GO:0043312
The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.
|
2 | O75015 (/TAS) P12318 (/TAS) |
Mast cell activation GO:0045576
The change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors.
|
2 | P08508 (/IDA) P08508 (/IDA) |
Mast cell activation GO:0045576
The change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors.
|
2 | P08508 (/IMP) P08508 (/IMP) |
Positive regulation of phagocytosis, engulfment GO:0060100
Any process that activates or increases the frequency, rate or extent of the internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis.
|
2 | A0A0B4J2J0 (/IMP) A0A0G2K3P6 (/IMP) |
Interferon-gamma-mediated signaling pathway GO:0060333
A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far.
|
2 | P12314 (/TAS) Q92637 (/TAS) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
2 | Q63203 (/IEP) Q63203 (/IEP) |
Response to epinephrine GO:0071871
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system.
|
2 | A0A0B4J2J0 (/IEP) A0A0G2K3P6 (/IEP) |
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
|
1 | P20489 (/IDA) |
Negative regulation of type I hypersensitivity GO:0001811
Any process that stops, prevents, or reduces the rate of type I hypersensitivity, a type of inflammatory response.
|
1 | P08101 (/IMP) |
Negative regulation of type I hypersensitivity GO:0001811
Any process that stops, prevents, or reduces the rate of type I hypersensitivity, a type of inflammatory response.
|
1 | P31994 (/ISS) |
Regulation of antibody-dependent cellular cytotoxicity GO:0001813
Any process that modulates the frequency, rate, or extent of antibody-dependent cellular cytotoxicity.
|
1 | P27645 (/IMP) |
Negative regulation of antibody-dependent cellular cytotoxicity GO:0001814
Any process that stops, prevents, or reduces the rate of antibody-dependent cellular cytotoxicity.
|
1 | P31994 (/TAS) |
Serotonin secretion GO:0001820
The regulated release of serotonin by a cell. Serotonin (5-hydroxytryptamine, or 5-HT) is a monoamine synthesised in serotonergic neurons in the central nervous system, enterochromaffin cells in the gastrointestinal tract and some immune system cells.
|
1 | P20489 (/IMP) |
Follicular dendritic cell activation GO:0002266
A change in the morphology or behavior of a follicular dendritic cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
1 | P31994 (/TAS) |
Mature B cell differentiation involved in immune response GO:0002313
The process in which a naive B cell acquires the specialized features of a mature or memory B cell during an immune response.
|
1 | P31994 (/TAS) |
Follicular B cell differentiation GO:0002316
The process in which a B cell in the spleen acquires the specialized features of a follicular B cell. Follicular B cells are major population of mature recirculating B cells in the spleen and are located in the B-cell follicle region.
|
1 | P31994 (/TAS) |
Immune complex clearance GO:0002434
A process directed at removing immune complexes from the body. Immune complexes are clusters of antibodies bound to antigen, to which complement may also be fixed, and which may precipitate or remain in solution.
|
1 | P08101 (/ISO) |
Immune complex clearance by monocytes and macrophages GO:0002436
The process of immune complex clearance by monocytes or macrophages.
|
1 | P31994 (/TAS) |
Negative regulation of dendritic cell antigen processing and presentation GO:0002605
Any process that stops, prevents, or reduces the frequency, rate, or extent of dendritic cell antigen processing and presentation.
|
1 | P31994 (/TAS) |
Regulation of B cell antigen processing and presentation GO:0002622
Any process that modulates the frequency, rate, or extent of B cell antigen processing and presentation.
|
1 | P31994 (/TAS) |
Negative regulation of immunoglobulin production GO:0002638
Any process that stops, prevents, or reduces the frequency, rate, or extent of immunoglobulin production.
|
1 | P08101 (/IMP) |
Negative regulation of immunoglobulin production GO:0002638
Any process that stops, prevents, or reduces the frequency, rate, or extent of immunoglobulin production.
|
1 | P31994 (/ISS) |
Regulation of adaptive immune response GO:0002819
Any process that modulates the frequency, rate, or extent of an adaptive immune response.
|
1 | P31994 (/TAS) |
Negative regulation of inflammatory response to antigenic stimulus GO:0002862
Any process that stops, prevents, or reduces the frequency, rate, or extent of an inflammatory response to an antigenic stimulus.
|
1 | P08101 (/IMP) |
Negative regulation of acute inflammatory response to antigenic stimulus GO:0002865
Any process that stops, prevents, or reduces the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus.
|
1 | P08101 (/IMP) |
Negative regulation of acute inflammatory response to antigenic stimulus GO:0002865
Any process that stops, prevents, or reduces the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus.
|
1 | P31994 (/ISS) |
Positive regulation of humoral immune response GO:0002922
Any process that activates or increases the frequency, rate, or extent of a humoral immune response.
|
1 | P31994 (/TAS) |
Negative regulation of humoral immune response mediated by circulating immunoglobulin GO:0002924
Any process that stops, prevents, or reduces the frequency, rate, or extent of a humoral immune response mediated by circulating immunoglobulin.
|
1 | P08101 (/IMP) |
Negative regulation of humoral immune response mediated by circulating immunoglobulin GO:0002924
Any process that stops, prevents, or reduces the frequency, rate, or extent of a humoral immune response mediated by circulating immunoglobulin.
|
1 | P31994 (/ISS) |
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
|
1 | P26151 (/IMP) |
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
|
1 | P08101 (/ISO) |
Phagocytosis, engulfment GO:0006911
The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis.
|
1 | P08101 (/IDA) |
Phagocytosis, engulfment GO:0006911
The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis.
|
1 | P31994 (/ISS) |
Phagocytosis, engulfment GO:0006911
The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis.
|
1 | P12314 (/TAS) |
Defense response GO:0006952
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
|
1 | P08101 (/IMP) |
Defense response GO:0006952
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
|
1 | P31994 (/ISS) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
1 | P31994 (/TAS) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
1 | P20489 (/IDA) |
Cell surface receptor signaling pathway GO:0007166
A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
1 | P20489 (/IDA) |
Activation of JUN kinase activity GO:0007257
The initiation of the activity of the inactive enzyme JUN kinase (JNK).
|
1 | P20489 (/IDA) |
Response to bacterium GO:0009617
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium.
|
1 | P31994 (/ISS) |
Regulation of signaling receptor activity GO:0010469
Any process that modulates the frequency, rate or extent of a signaling receptor activity. Receptor activity is when a molecule combines with an extracellular or intracellular messenger to initiate a change in cell activity.
|
1 | P31994 (/TAS) |
Immunoglobulin mediated immune response GO:0016064
An immune response mediated by immunoglobulins, whether cell-bound or in solution.
|
1 | P08101 (/IMP) |
Immunoglobulin mediated immune response GO:0016064
An immune response mediated by immunoglobulins, whether cell-bound or in solution.
|
1 | P31994 (/ISS) |
Dendrite development GO:0016358
The process whose specific outcome is the progression of the dendrite over time, from its formation to the mature structure.
|
1 | P08101 (/IMP) |
Leukotriene biosynthetic process GO:0019370
The chemical reactions and pathways resulting in the formation of leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid.
|
1 | P20489 (/IDA) |
Antigen processing and presentation of exogenous antigen GO:0019884
The process in which an antigen-presenting cell expresses antigen (peptide or lipid) of exogenous origin on its cell surface in association with an MHC protein complex.
|
1 | P26151 (/IMP) |
Antigen processing and presentation of exogenous peptide antigen via MHC class II GO:0019886
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
|
1 | P08101 (/IMP) |
Antigen processing and presentation of exogenous peptide antigen via MHC class II GO:0019886
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
|
1 | P31994 (/ISS) |
Cerebellum development GO:0021549
The process whose specific outcome is the progression of the cerebellum over time, from its formation to the mature structure. The cerebellum is the portion of the brain in the back of the head between the cerebrum and the pons. In mice, the cerebellum controls balance for walking and standing, modulates the force and range of movement and is involved in the learning of motor skills.
|
1 | P08101 (/IMP) |
Cerebellum development GO:0021549
The process whose specific outcome is the progression of the cerebellum over time, from its formation to the mature structure. The cerebellum is the portion of the brain in the back of the head between the cerebrum and the pons. In mice, the cerebellum controls balance for walking and standing, modulates the force and range of movement and is involved in the learning of motor skills.
|
1 | P31994 (/ISS) |
Nerve development GO:0021675
The process whose specific outcome is the progression of a nerve over time, from its formation to the mature structure.
|
1 | P27645 (/IEP) |
Negative regulation of B cell proliferation GO:0030889
Any process that stops, prevents or reduces the rate or extent of B cell proliferation.
|
1 | P08101 (/IMP) |
Negative regulation of B cell proliferation GO:0030889
Any process that stops, prevents or reduces the rate or extent of B cell proliferation.
|
1 | P31994 (/ISS) |
Endocytic recycling GO:0032456
The directed movement of membrane-bounded vesicles from recycling endosomes back to the plasma membrane where they are recycled for further rounds of transport.
|
1 | P08101 (/ISO) |
Negative regulation of interleukin-10 production GO:0032693
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-10 production.
|
1 | P08101 (/IMP) |
Negative regulation of interleukin-10 production GO:0032693
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-10 production.
|
1 | P31994 (/ISS) |
Negative regulation of neutrophil apoptotic process GO:0033030
Any process that stops, prevents, or reduces the frequency, rate, or extent of neutrophil apoptotic process.
|
1 | P08101 (/ISO) |
Fc-epsilon receptor signaling pathway GO:0038095
A series of molecular signals initiated by the binding of the Fc portion of immunoglobulin E (IgE) to an Fc-epsilon receptor on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region.
|
1 | P12319 (/TAS) |
Fc-gamma receptor signaling pathway involved in phagocytosis GO:0038096
An Fc-gamma receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes.
|
1 | P31994 (/IDA) |
Fc-gamma receptor signaling pathway involved in phagocytosis GO:0038096
An Fc-gamma receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes.
|
1 | P08101 (/ISO) |
Neutrophil activation GO:0042119
The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
1 | A0A0B4J1G0 (/IMP) |
Neutrophil activation GO:0042119
The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
1 | H0VDZ8 (/ISS) |
Defense response to bacterium GO:0042742
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
1 | P26151 (/IMP) |
Negative regulation of macrophage activation GO:0043031
Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage activation.
|
1 | P31994 (/TAS) |
Positive regulation of mast cell degranulation GO:0043306
Any process that activates or increases the frequency, rate or extent of mast cell degranulation.
|
1 | P20489 (/IDA) |
Negative regulation of cytotoxic T cell degranulation GO:0043318
Any process that stops, prevents, or reduces the rate of cytotoxic T cell degranulation.
|
1 | P31994 (/TAS) |
Regulation of innate immune response GO:0045088
Any process that modulates the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.
|
1 | P31994 (/TAS) |
Positive regulation of interleukin-3 biosynthetic process GO:0045401
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-3.
|
1 | P20489 (/IDA) |
Positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process GO:0045425
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of granulocyte macrophage colony-stimulating factor.
|
1 | P20489 (/IDA) |
Positive regulation of bone resorption GO:0045780
Any process that activates or increases the frequency, rate or extent of bone resorption.
|
1 | A0A0B4J1G0 (/IMP) |
Positive regulation of bone resorption GO:0045780
Any process that activates or increases the frequency, rate or extent of bone resorption.
|
1 | H0VDZ8 (/ISS) |
Positive regulation of JNK cascade GO:0046330
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade.
|
1 | P08101 (/IMP) |
Positive regulation of JNK cascade GO:0046330
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade.
|
1 | P31994 (/ISS) |
Regulation of long-term neuronal synaptic plasticity GO:0048169
A process that modulates long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers.
|
1 | P08101 (/IMP) |
Negative regulation of cytokine secretion GO:0050710
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of cytokines from a cell.
|
1 | P31994 (/TAS) |
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
1 | P20489 (/IDA) |
Negative regulation of phagocytosis GO:0050765
Any process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis.
|
1 | P08101 (/IMP) |
Negative regulation of phagocytosis GO:0050765
Any process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis.
|
1 | P31994 (/TAS) |
Positive regulation of phagocytosis GO:0050766
Any process that activates or increases the frequency, rate or extent of phagocytosis.
|
1 | P08101 (/IDA) |
Positive regulation of phagocytosis GO:0050766
Any process that activates or increases the frequency, rate or extent of phagocytosis.
|
1 | P31994 (/ISS) |
Negative regulation of immune response GO:0050777
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
1 | P08101 (/IMP) |
Negative regulation of immune response GO:0050777
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
1 | P31994 (/ISS) |
Positive regulation of calcium-mediated signaling GO:0050850
Any process that activates or increases the frequency, rate or extent of calcium-mediated signaling.
|
1 | P20489 (/IDA) |
Negative regulation of B cell receptor signaling pathway GO:0050859
Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell.
|
1 | P31994 (/IMP) |
Negative regulation of B cell receptor signaling pathway GO:0050859
Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell.
|
1 | P08101 (/ISO) |
Negative regulation of B cell activation GO:0050869
Any process that stops, prevents, or reduces the frequency, rate or extent of B cell activation.
|
1 | P31994 (/TAS) |
Positive regulation of DNA-binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
1 | P08101 (/IMP) |
Regulation of sensory perception of pain GO:0051930
Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal.
|
1 | A0A0B4J1G0 (/ISO) |
Positive regulation of phagocytosis, engulfment GO:0060100
Any process that activates or increases the frequency, rate or extent of the internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis.
|
1 | P26151 (/ISO) |
Positive regulation of protein tyrosine kinase activity GO:0061098
Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.
|
1 | P12314 (/IMP) |
Positive regulation of protein tyrosine kinase activity GO:0061098
Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.
|
1 | P26151 (/ISO) |
Cellular response to molecule of bacterial origin GO:0071219
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
|
1 | P08101 (/IMP) |
Cellular response to molecule of bacterial origin GO:0071219
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
|
1 | P31994 (/ISS) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | A0A0B4J1G0 (/ISO) |
Regulation of immune complex clearance by monocytes and macrophages GO:0090264
Any process that modulates the rate, frequency, or extent of the process of immune complex clearance by monocytes or macrophages.
|
1 | P31994 (/TAS) |
Positive regulation of neuron death GO:1901216
Any process that activates or increases the frequency, rate or extent of neuron death.
|
1 | P08101 (/ISO) |
Positive regulation of neuron death GO:1901216
Any process that activates or increases the frequency, rate or extent of neuron death.
|
1 | P31994 (/ISS) |
Negative regulation of neutrophil activation GO:1902564
Any process that stops, prevents or reduces the frequency, rate or extent of neutrophil activation.
|
1 | P31994 (/TAS) |
Regulation of dendritic spine maintenance GO:1902950
Any process that modulates the frequency, rate or extent of dendritic spine maintenance.
|
1 | P31994 (/IGI) |
Regulation of dendritic spine maintenance GO:1902950
Any process that modulates the frequency, rate or extent of dendritic spine maintenance.
|
1 | P08101 (/IMP) |
Regulation of dendritic spine maintenance GO:1902950
Any process that modulates the frequency, rate or extent of dendritic spine maintenance.
|
1 | P08101 (/ISO) |
Regulation of tumor necrosis factor secretion GO:1904467
Any process that modulates the frequency, rate or extent of tumor necrosis factor secretion.
|
1 | P27645 (/IMP) |
Cellular response to amyloid-beta GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
1 | P08101 (/ISO) |
Cellular response to amyloid-beta GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
1 | P31994 (/ISS) |
Regulation of Fc-gamma receptor signaling pathway involved in phagocytosis GO:1905449
Any process that modulates the frequency, rate or extent of Fc-gamma receptor signaling pathway involved in phagocytosis.
|
1 | P27645 (/IMP) |
Positive regulation of response to endoplasmic reticulum stress GO:1905898
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
|
1 | P08101 (/ISO) |
Positive regulation of response to endoplasmic reticulum stress GO:1905898
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
|
1 | P31994 (/ISS) |
Negative regulation of dendritic cell differentiation GO:2001199
Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell differentiation.
|
1 | P31994 (/TAS) |
There are 30 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
10 | A0A0B4J1G0 (/IDA) A0A0B4J2J1 (/IDA) A0A0G2K8U8 (/IDA) P08508 (/IDA) P08508 (/IDA) P12319 (/IDA) P27645 (/IDA) Q63203 (/IDA) Q63203 (/IDA) Q6XPU4 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
7 | O75015 (/TAS) P08637 (/TAS) P12314 (/TAS) P12318 (/TAS) P12319 (/TAS) P31994 (/TAS) Q92637 (/TAS) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
6 | P08101 (/IDA) P08508 (/IDA) P08508 (/IDA) P08637 (/IDA) P20489 (/IDA) P26151 (/IDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
5 | A0A0B4J1G0 (/ISO) P08101 (/ISO) P08508 (/ISO) P08508 (/ISO) P20489 (/ISO) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
4 | A0A0B4J2J0 (/IDA) A0A0G2K3P6 (/IDA) Q63203 (/IDA) Q63203 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | P08101 (/IDA) P12314 (/IDA) P31994 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | P12318 (/NAS) P31994 (/NAS) Q92637 (/NAS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | P08101 (/ISO) P26151 (/ISO) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
2 | P20489 (/IDA) P31994 (/IDA) |
Secretory granule membrane GO:0030667
The lipid bilayer surrounding a secretory granule.
|
2 | O75015 (/TAS) P12318 (/TAS) |
Clathrin-coated endocytic vesicle membrane GO:0030669
The lipid bilayer surrounding a clathrin-coated endocytic vesicle.
|
2 | P12314 (/TAS) Q92637 (/TAS) |
Early endosome membrane GO:0031901
The lipid bilayer surrounding an early endosome.
|
2 | P12314 (/TAS) Q92637 (/TAS) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
2 | P08101 (/ISO) P26151 (/ISO) |
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
|
2 | Q63203 (/IDA) Q63203 (/IDA) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
2 | O75015 (/HDA) P08637 (/HDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
1 | O75015 (/TAS) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | P08101 (/IC) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | P08101 (/ISO) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | P12319 (/TAS) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
1 | A0A0B4J1G0 (/ISO) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
1 | P31994 (/ISS) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
1 | H0VDZ8 (/ISS) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | P08101 (/IDA) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | P31995 (/NAS) |
Dendritic spine GO:0043197
A small, membranous protrusion from a dendrite that forms a postsynaptic compartment - typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable including \thin\, \stubby\, \mushroom\, and \branched\, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity.
|
1 | P08101 (/IDA) |
Dendritic spine GO:0043197
A small, membranous protrusion from a dendrite that forms a postsynaptic compartment - typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable including \thin\, \stubby\, \mushroom\, and \branched\, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity.
|
1 | P31994 (/ISS) |
Cell body GO:0044297
The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections.
|
1 | P08101 (/IDA) |
Cell body GO:0044297
The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections.
|
1 | P31994 (/ISS) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
1 | P20489 (/TAS) |
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
|
1 | P08101 (/ISO) |